Greenwich Lifesciences Net Debt To E B I T D A Over Time
| GLSI Stock | USD 13.51 0.30 2.27% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Greenwich Lifesciences Performance and Greenwich Lifesciences Correlation. Greenwich |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Greenwich Lifesciences. If investors know Greenwich will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Greenwich Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.81) | Return On Assets (0.72) | Return On Equity (1.24) |
The market value of Greenwich Lifesciences is measured differently than its book value, which is the value of Greenwich that is recorded on the company's balance sheet. Investors also form their own opinion of Greenwich Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Greenwich Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Greenwich Lifesciences' market value can be influenced by many factors that don't directly affect Greenwich Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Greenwich Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Greenwich Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Greenwich Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Debt To E B I T D A Analysis
Compare Greenwich Lifesciences and related stocks such as Puma Biotechnology, Iovance Biotherapeutics, and Inozyme Pharma Net Debt To E B I T D A Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PBYI | 0.0932 | 5.2221 | 1.8546 | 0.7911 | 0.2718 | 0.1319 | 0.7061 | 0.1152 | (0.4568) | (1.0809) | (0.9251) | (9.9205) | 1.8161 | 0.5661 | 0.59 |
| IOVA | 0.0521 | (0.2186) | 12.7478 | 0.7891 | 3.7592 | 3.8896 | 3.2065 | 1.5955 | 0.67 | 0.013 | 0.0625 | 0.0204 | 0.393 | 0.0913 | 0.0867 |
| INZY | 3.1094 | 3.1094 | 3.1094 | 3.1094 | 3.1094 | 3.1094 | 3.1094 | 3.1094 | 3.1094 | 1.5251 | 2.7912 | 0.3563 | 0.3967 | (0.1605) | (0.15) |
| ZNTL | 1.0599 | 1.0599 | 1.0599 | 1.0599 | 1.0599 | 1.0599 | 1.0599 | 1.0599 | 1.0599 | 1.7469 | 0.449 | 0.0842 | (0.0095) | (0.0549) | (0.0521) |
| SNDX | (3.957) | (3.957) | (3.957) | 1.1806 | (0.1818) | 1.1311 | 0.5459 | 0.5683 | 0.4571 | 0.4265 | 1.3475 | (7.3677) | 0.4823 | 1.2775 | 1.34 |
| PTGX | 1.029 | 1.029 | 1.029 | 1.029 | 1.029 | 0.2788 | 0.6518 | 2.9009 | 2.098 | 0.2043 | 1.7499 | 0.9572 | 0.9293 | 2.0543 | 1.03 |
Greenwich Lifesciences and related stocks such as Puma Biotechnology, Iovance Biotherapeutics, and Inozyme Pharma Net Debt To E B I T D A description
A leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA).My Equities
My Current Equities and Potential Positions
| Greenwich Lifesciences | GLSI |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Texas; U.S.A |
| Exchange | NASDAQ Exchange |
USD 13.51
Check out Greenwich Lifesciences Performance and Greenwich Lifesciences Correlation. For more detail on how to invest in Greenwich Stock please use our How to Invest in Greenwich Lifesciences guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Greenwich Lifesciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.